Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JFL Life SciencesNSE:JFLLIFE 67 Days Inventory is 107.86 as of Mar. 2025, which is at its 10-year median of 107.86. GuruFocus rates NSE:JFLLIFE with a GF Score™ of 67/100 and a GF Value™ of ₹35.89 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 923 Drug Manufacturers companies, JFL Life Sciences ranks better than 75.73% on this metric.
The historical rank and industry rank for JFL Life Sciences's Days Inventory or its related term are showing as below:
NSE:JFLLIFE'
s Days Inventory Range Over the Past 10 Years
Min: 21.4 Med: 107.86 Max: 146.39
Current: 107.86
During the past 7 years, JFL Life Sciences's highest Days Inventory was 146.39. The lowest was 21.40. And the median was 107.86.
NSE:JFLLIFE's Days Inventory is ranked better than 75.73% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:JFLLIFE: 107.86
JFL Life Sciences's Days Inventory
declined
from Mar. 2023 (141.49) to Mar. 2025 (107.86).
Inventory Turnover measures how fast the company turns over its inventory within a year.
JFL Life Sciences's Inventory Turnover for the
six
months ended in Mar. 2025 was 3.38.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
JFL Life Sciences's Inventory-to-Revenue for the
six
months ended in Mar. 2025 was 0.24.
JFL Life Sciences (NSE:JFLLIFE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
JFL Life Sciences's Inventory Turnover for the
six
months ended in Mar. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
JFL Life Sciences's Inventory to Revenue for the
six
months ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
JFL Life Sciences Days Inventory Related Terms
JFL Life Sciences Days Inventory Historical Data
* Premium members only.
The historical data trend for JFL Life Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:JFLLIFE vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, JFL Life Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JFL Life Sciences Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, JFL Life Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where JFL Life Sciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JFL Life Sciences (NSE:JFLLIFE) has a Days Inventory of 107.86 as of Mar. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on JFL Life Sciences and its competitors. This is near median its historical median of 107.86. Over the past decade, JFL Life Sciences' Days Inventory has ranged from 21.40 to 146.39. According to the industry distribution chart, JFL Life Sciences ranks #224 out of 923 companies in the Drug Manufacturers industry, placing it in the top 24.3%.
Is JFL Life Sciences' Days Inventory too high?
JFL Life Sciences' current Days Inventory of 107.86 is near median its 10-year median of 107.86. Over the past 10 years, this metric has ranged from a low of 21.40 to a high of 146.39. The Drug Manufacturers industry median Days Inventory is 164.48. JFL Life Sciences' value of 107.86 is 34.4% below this industry median. Based on the distribution chart, JFL Life Sciences ranks #224 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, JFL Life Sciences has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JFL Life Sciences' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, JFL Life Sciences ranks #224 out of 923 companies for Days Inventory. This places JFL Life Sciences in the top 24% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. JFL Life Sciences' value of 107.86 is 34.4% below this benchmark. Historically, JFL Life Sciences' own Days Inventory has ranged from 21.40 to 146.39 over the past decade. While the company's 10-year median is 107.86 vs. the industry median of 164.48, JFL Life Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JFL Life Sciences's current Days Inventory of 107.86 is 34.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on JFL Life Sciences and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JFL Life Sciences's current Days Inventory is 107.86, which is near median its own 10-year median of 107.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JFL Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, JFL Life Sciences (NSE:JFLLIFE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹35.89, compared to a current price of ₹10.60 — trading 70.5% below its estimated fair value. The current Days Inventory is 107.86, which is near median its 10-year median of 107.86 and 34.4% below the Drug Manufacturers industry median of 164.48. JFL Life Sciences' overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For JFL Life Sciences (NSE:JFLLIFE), the current Days Inventory is 107.86 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JFL Life Sciences (NSE:JFLLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, JFL Life Sciences stock appears to be undervalued.
The current stock price of ₹10.60 is trading 70.5% below its estimated GF Value™ of ₹35.89.
GuruFocus considers JFL Life Sciences to be Significantly Undervalued.
Key valuation signals for NSE:JFLLIFE:
Days Inventory: 107.86 (near median its 10-year median of 107.86)
GF Value™: ₹35.89 vs. price of ₹10.60 (70.5% below fair value)
Industry Position: 34.4% below the Drug Manufacturers median (#224 of 923)
No single metric tells the full story. See the NSE:JFLLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
67GF Score
Get the complete analysis for NSE:JFLLIFE
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JFLLIFE has been successfully added to your 
